Search

everythinglearnresearchcommunity

for

Search:↓

The rs231775 genetic variant is linked to a higher risk and severity of Alopecia Areata in males.

Olumiant should be covered for severe alopecia areata if certain conditions are met.

Patients prefer the higher 50 mg dose of ritlecitinib for better hair regrowth despite higher risks.

Combining Ficlatuzumab and Gefitinib can cause severe hair loss.

5-Alpha reductase inhibitors may prevent prostate cancer but are not widely used due to concerns about trial relevance and potential risks, and more research is needed to confirm long-term benefits.

AI can accurately measure hair loss severity in alopecia areata.

The androgen receptor gene doesn't affect women with recurrent spontaneous abortions, but having a mutant genotype might protect against it.

Deucravacitinib helped a man regrow hair and improve psoriasis.

Antiandrogens help improve developmental delays caused by valproic acid in rats.

Genetic profiling can improve androgenetic alopecia treatment by predicting drug response and minimizing side effects.

ALRV5XR is the most effective hair regrowth treatment at 24 weeks.

The AAcQLI is a promising tool for assessing quality of life in children with alopecia areata.

HDAC inhibitors, like Vorinostat and Entinostat, can help regrow hair in alopecia areata.

African American men with prostate cancer have more androgen receptor mutations, which may lead to more aggressive cancer compared to Caucasian American men.

Cinacalcet may help treat hereditary vitamin D resistant rickets safely.

Peginterferon alfa-2b and ribavirin therapy for hepatitis C can cause serious side effects, some different from those reported in clinical trials.

AS101 reduces hair loss from chemotherapy.

Anti-DFS70 antibodies can help identify nonsystemic autoimmune conditions in SLE patients.

The decision board effectively helps lupus nephritis patients in Brazil choose treatments by clearly presenting options and side effects.

A specific gene variant may increase the risk of developing Alopecia Areata.

Patients with Alopecia Areata are willing to trade life duration for better quality of life.

A mutation in the HR gene causes a rare form of irreversible hair loss in two Kashmiri families. Whole exome sequencing is effective for finding such mutations.

The research developed methods to test drugs that could protect and restore hair follicle protection in a hair loss condition.

Gene variation affects prostate issues and hair loss.

Baricitinib 4 mg is effective and safe for treating severe alopecia areata.

Alisertib was found to be an effective and tolerable treatment for children with recurrent brain tumors.

A standardized scoring system is needed to improve model reliability for predicting hair loss in brain tumor patients treated with proton therapy.

A new method can quickly and accurately detect drugs in hair.

5α-reductase inhibitors can reduce prostate cancer risk but may increase high-grade tumors, needing more research.